17-N-Allylamino-17-Demethoxygeldanamycin

tanespimycin

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for 17-N-Allylamino-17-Demethoxygeldanamycin, covering 2011-08-03 to 2013-06-24. Get the full timeline:

Most recent: Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer [Phase 2]